J B Chemicals & Pharmaceuticals Ltd Financial Statements

JBCHEPHARM Profit and Loss

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2018
Revenue 2,424 2,043 1,775 1,409
yoy growth (%) 18.70 15.10 26 4.81
Raw materials (843) (701) (631) (538)
As % of sales 34.80 34.30 35.50 38.20
Employee costs (439) (341) (323) (251)
As % of sales 18.10 16.70 18.20 17.80
Other costs (599) (440) (443) (402)
As % of sales 24.70 21.50 25 28.50
Operating profit 543 560 378 218
OPM 22.40 27.40 21.30 15.50
Depreciation (73) (69) (66) (57)
Interest expense (5.10) (7.20) (3) (3.50)
Other income 39.20 112 50.70 36.60
Profit before tax 505 597 359 194
Taxes (119) (148) (77) (55)
Tax rate (24) (25) (21) (28)
Minorities and other (0.70) (0.60) (0.30) (0.40)
Adj. profit 385 448 282 138
Exceptional items -- -- (10) --
Net profit 385 448 272 138
yoy growth (%) (14) 64.70 96.60 (25)
NPM 15.90 21.90 15.30 9.82

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

Open Demat Account
  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity